Symbol | Exchange | Currency | ||
|---|---|---|---|---|
| NYSE | USD | Real-time | ||
| NSE | INR | Delayed | ||
| Mexico | MXN | Delayed | ||
| Stockholm | SEK | Real-time | ||
| NSE | INR | Real-time | ||
| BSE | INR | Delayed | ||
| Hamburg | EUR | Delayed | ||
| Xetra | EUR | Delayed | ||
| Frankfurt | EUR | Delayed | ||
| TradeGate | EUR | Delayed | ||
| Santiago | USD | Delayed | ||
| Buenos Aires | ARS | Delayed | ||
| BM&FBovespa | BRL | Delayed | ||
| Vienna | EUR | Delayed | ||
| Moscow | RUB | Real-time | ||
| KASE | KZT | Delayed | ||
| Lima | USD | Delayed |
By Trevor Hunnicutt and Jeff Mason WASHINGTON (Reuters) -U.S. President Joe Biden on Tuesday urged Republican leaders in Florida and Texas - home to roughly a third of all new...
The U.S. Food and Drug Administration is aiming to grant full approval of the Pfizer-BioNTech coronavirus vaccine by Labor Day or sooner, according to a new report.
J&J recipients can make special requests to get a "supplemental dose" of an mRNA vaccine, San Francisco health officials said in a statement to CNBC.
The pandemic has triggered a race to introduce vaccines and treatment options, opening up investing opportunities in the biotech sector over the past year. Thus, the sector has...
The agency will now ‘sprint’ to grant full vaccine approval.
Moderna, Pfizer Hike Vaccine Prices By Up To 25%Pfizer and Moderna have both made clear that they see their COVID vaccination businesses as long-term profit drivers, not the...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Technical Indicators | Buy | Buy | Strong Buy | Strong Buy | Strong Buy |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 351.24 | 353.77 | 347.70 | -0.71 | -0.20% | 12.41M | NASDAQ | |||
| 2,712.60 | 2,714.60 | 2,666.40 | +15.5 | +0.58% | 1.04M | NASDAQ | |||
| 103.06 | 103.20 | 98.11 | +2.46 | +2.45% | 14.44M | NYSE | |||
| 197.38 | 197.44 | 192.00 | -2.71 | -1.35% | 20.12M | NYSE | |||
| 4.44 | 4.47 | 4.44 | 0.000 | 0.00% | 0.00 | NYSE | |||
| 21.72 | 21.77 | 21.53 | +0.15 | +0.70% | 10.74M | NYSE | |||
| 198.15 | 202.22 | 192.20 | +0.65 | +0.33% | 30.18M | NASDAQ | |||
| 19.74 | 19.84 | 18.99 | +0.48 | +2.49% | 7.61M | NYSE | |||
| 6.52 | 6.556 | 6.45 | +0.020 | +0.31% | 6.80M | NYSE | |||
| 64.03 | 64.65 | 63.95 | -0.06 | -0.09% | 612.48K | NYSE | |||
| 1.08 | 1.10 | 1.06 | -0.0100 | -0.92% | 3.09M | NYSE | |||
| 13.64 | 13.68 | 13.42 | +0.10 | +0.74% | 2.37M | NYSE | |||
| 0.61 | 0.00 | 0.00 | +0.0058 | +0.96% | 676.00K | NYSE | |||
| 230.18 | 235.69 | 226.91 | -5.22 | -2.22% | 2.85M | NASDAQ | |||
| 79.84 | 79.93 | 78.96 | +0.32 | +0.40% | 583.43K | NYSE |
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Prevnar 13/Prevenar 13 (pediatric/adult), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Pfizer-BioNTech COVID-19 vaccine brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa/Staquis brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; Arvinas, Inc.; and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
